Top Dutch Court Upholds Bristol-Myers' Apixaban Patent
The top court in the Netherlands on Friday dashed Sandoz and Teva's latest bid to revoke Bristol-Myers Squibb's apixaban patent protections, upholding an earlier ruling that the patent is valid....To view the full article, register now.
Already a subscriber? Click here to view full article